Skip to main content

Table 2 Tumor response after GSMs-TACE treatment (n, %)

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

Post-operation n CR (%) PR (%) SD (%) PD (%) ORR (%) DCR (%)
1 month 27 7 (25.93) 13 (48.15) 6 (22.22) 1 (3.70) 20 (74.07) 26 (96.30)